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Context: Standardized description of external genitalia is needed in the assessment of children 
with atypical genitalia.
Objectives: To validate the External Genitalia Score (EGS), to present reference values for 
preterm and term babies up to 24 months and correlate obtained scores with anogenital 
distances (AGDs).
Design, Setting: A European multicenter (n = 8) validation study was conducted from July 2016 
to July 2018.
Patients and Methods: EGS is based on the external masculinization score but uses a gradual 
scale from female to male (range, 0–12) and terminology appropriate for both sexes. The 
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reliability of EGS and AGDs was determined by the interclass correlation coefficient (ICC). Cross-
sectional data were obtained in 686 term babies (0–24 months) and 181 preterm babies, and 
111 babies with atypical genitalia.
Results: The ICC of EGS in typical and atypical genitalia is excellent and good, respectively. 
Median EGS (10th to 90th centile) in males < 28 weeks gestation is 10 (8.6–11.5); in males 28–32 
weeks 11.5 (9.2–12); in males 33–36 weeks 11.5 (10.5–12) and in full-term males 12 (10.5–12). 
In all female babies, EGS is 0 (0-0). The mean (SD) lower/upper AGD ratio (AGDl/u) is 0.45 (0.1), 
with significant difference between AGDl/u in males 0.49 (0.1) and females 0.39 (0.1) and 
intermediate values in differences of sex development (DSDs) 0.43 (0.1). The AGDl/u correlates 
with EGS in males with typical genitalia and in atypical genitalia.
Conclusions: EGS is a reliable and valid tool to describe external genitalia in premature and 
term babies up to 24 months. EGS correlates with AGDl/u in males. It facilitates standardized 
assessment, clinical decision-making and multicenter research. (J Clin Endocrinol Metab 105: 
1–9, 2020)
Key Words: external genitalia score, external masculinization score, anogenital distances, 
atypical genitalia
Differences (or disorders) of sex development (DSDs) are heterogeneous congenital conditions that af-
fect the development of the urogenital tract and repro-
ductive system and result in atypical sex differentiation 
(1–4). The incidence of DSDs where sex assignment may 
be unclear at birth is estimated at 1/5500 births (5). For 
milder variations, such as hypospadias, prevalence rates 
vary from 13.8/10 000 to 40/10 000 (6, 7). The clin-
ical management of these conditions is complex and re-
quires specialized care by a multidisciplinary team (1, 
8). A  precise understanding of the underlying cause, 
preferably up to the molecular genetic level, is crucial to 
allow individualized management as well as for research 
purposes. Detailed evaluation of the genital phenotype 
will inform clinicians about the need for further referral 
to an expert center, and guide them to specific diag-
nostic tests such as hormonal, imaging, and genetic in-
vestigations (9). The genital phenotype at birth has also 
been related to long-term outcomes, such as with regard 
to genital (dis)satisfaction (10), the prevalence of car-
diac (11) or other comorbidities (12) or the risk for the 
development of gonadal germ cell tumors (13, 14). The 
relevance of a precise description of the genital pheno-
type has even increased in recent years as genital surgery 
in childhood has become controversial, and currently 
many children who have a DSD grow up with a genital 
difference. The long-term outcome of this approach will 
need to be determined. Lastly, given that the individual 
DSD conditions are (very) rare, meaningful research re-
quires a multicenter approach and thus a standardized 
battery of tools across centers to assess and document 
this phenotypic variability.
A comprehensive genital exam contains the following 
landmarks: the presence and location of the gonads, 
genital tubercle development, degree of fusion of the 
labioscrotal folds and location of the urethral meatus. 
A micropenis is defined as a short penis, ≤ 24–25 mm (ie, 
≤ 2.5 SD below the mean) with a normal configuration 
(15). Minor racial differences for stretched penile length 
have been published (16). The distance between the anus 
and various landmarks of the external genitalia has 
been shown to be a sensitive index of androgen activity 
during fetal development and is sexually dimorphic (17, 
18). Various anogenital distances (AGDs) have been pro-
posed. In male term newborns, the mean (SD) anoscrotal 
anogenital distance (AGDas), measured from the center 
of the anus to the posterior scrotal wall is 24.7 (4.5) mm. 
In female term newborns the mean (SD) ano-fourchette 
AGD (AGDaf), measured from the center of the anus to 
the fourchette is 16.0 (3.2) mm (17). AGDas and AGDaf 
are represented in Fig. 1 as lower AGD (AGDl), while 
anopenile AGD (AGDap) and anoclitoral AGD (AGDac) 
are represented as upper AGD (AGDu). A shorter AGDas 
and penile length have been found in infants with hypo-
spadias and cryptorchidism, a longer AGDaf has been 
described in female infants with androgen excess, for 
example, in congenital adrenal hyperplasia (CAH). In 
typical female infants, it was shown that calculating 
the anogenital-ratio (AGDaf:AGDac) offers advan-
tages as it follows a normal distribution and does not 
correlate with anthropometric variables or gestational 
age (19, 20). The Prader score (PS) was developed by 
Andrea Prader in 1954 to capture genital variation in 
children who have CAH. Apart from the typical female 
and male phenotypes, it categorizes external genitalia 
in children with CAH in 5 additional stages with pro-
gressive virilization from a phenotypic female with mild 
clitoromegaly (stage 1) to a phenotypic male with glan-
dular hypospadias (stage 5) (21). In 2000, the External 
Masculinization Score (EMS) was introduced to improve 
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the initial assessment of boys with a genital difference. 
The EMS (range 0–12) allocates points to 5 different 
characteristics of the external genitalia (scrotal fusion 
3/0, micropenis < 25 mm 3/0, urethral meatus 3/2/1/0, 
right and left gonad 1,5/1/0) (22). The EMS allows stand-
ardization of genital assessment, but a refinement of the 
score is needed to capture the appearance of the genitalia 
more comprehensively across the phenotypic spectrum 
in both sexes. We here present the External Genitalia 
Score (EGS) (Table 1) (23) as a modified, nonbinary ver-
sion of EMS. EGS was developed by Working Group 1 
of the European Cooperation in Science and Technology 
(COST) Action BM1303. The EGS uses a gradual scale 
from female to male (range, 0–12) of the same anatom-
ical landmarks as the EMS. To provide a full descrip-
tion of the external genitalia, the various AGDs were 
measured and, in line with EGS, a gender-neutral lower/
upper AGD ratio (AGDl/u) was calculated as a marker 
of genital virilization independent of body (Fig. 1).
Materials and Methods
Based on expert opinion and group discussions, mem-
bers of the DSDnet COST Action (www.dsdnet.eu) Working 
Group 1 modified the existing EMS to describe the same ana-
tomical features with a refined categorical scale for the items 
labioscrotal fusion, urethral meatus, and the position of the 
gonads and a continuous scale for the size of the genital tu-
bercle, ranging from typical female to typical male (Table 1) 
(23). In addition, the vocabulary was adjusted in a way that 
suits both sexes.
Measurements
Genital assessment and measurements included EMS 
and EGS, PS, and AGDs. The same digital caliper (Carbon 
Fiber Digital Caliper, resolution: 0.1 mm, QST-Express, type 
QST008, China) was used for all measurements across centers. 
Length of the genital tubercle (GTL) was measured along its 
dorsal aspect in a nonerect state, gently stretching it between 
two fingers until the point of increased resistance, from the 
base of the genital tubercle (as close to the pubic bone as pos-
sible) to the tip of the glans and excluding the foreskin (15). 
The measurement was performed twice, and the mean was cal-
culated. Location of the gonads was determined by palpation, 
as described by Ogilvy-Stuart (3). The position of the meatus 
and degree of labioscrotal fusion were determined by visual in-
spection. AGD measurements were standardized according to 
the Infant Development and the Environment Study (TIDES) 
(17), with some modifications, and the accompanying training 
video (kindly provided by the TIDES research group) was dis-
tributed among participating centers. Modifications to the 
Figure 1. Measurement of anogenital distances. In order to obtain a single measure that is suitable for all babies, AGDap and AGDac were 
defined as AGDu, and AGDas and AGDaf as AGDl. Abbreviations: AGDl (AGDlower), measured from the center of the anus to the base of the 
labioscrotal border; AGDu (AGDupper), measured from the center of the anus to the anterior base of the genital tubercle
Table 1. External Genitalia Score Describes Phenotypic Features at 5 Anatomical Landmarks of the Genitalia: 
Degree of Labioscrotal Fusion, Length of the Genital Tubercle, Position of the Urethral Meatus, and Locations 
of the Right and Left Gonads. The Final Score is the Sum of Points Allocated to Features 1–5.
EGS Labioscrotal Fusion
Genital Tubercle  
Length (mm) Urethral Meatus Right Gonad Left Gonad
3 Fused >31 Top of the GT   
2.5  26–30 Coronal Glandular   
2   Along the GT   
1.5 Posterior fusion 21–25 At the GT base Labioscrotal Labioscrotal 
1  10–20 Labioscrotal Inguino-Labioscrotal Inguino-Labioscrotal
0.5    Inguinal Inguinal
0 Unfused < 10 Perineal Impalpable Impalpable
Abbreviations: EGS, External Genitalia Score; GT, genital tubercle 
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TIDES method include placement of the baby in the middle 
of the bed instead of at the edge to allow the same position in 
premature babies in the incubator. For the same reason, the 
fixed end of the caliper is held at the center of the anus, and the 
sliding part of the caliper is moved while measuring the AGDs. 
The sliding part touches but does not compress the skin at the 
anterior base of the genital tubercle to standardize measure-
ments in male and female infants. The examiner does not use a 
marker for the mid-anus position but chooses a wrinkle in the 
center of the anus to use for the measurement of the 2 AGDs. 
The average of 2 measurements is used for analysis instead of 
the average of 3 measurements. AGDl was measured from the 
center of the anus to the base of the labioscrotal border and 
AGDu was measured from the center of the anus to the an-
terior base of the genital tubercle. PS was determined by visual 
inspection and EMS, EGS, and AGDl/u were calculated based 
on the obtained scores and AGD measurements.
Participants
First, the inter-observer reliability of PS, EMS, EGS and 
inter- and intra-observer reliability of AGDl/u were deter-
mined by 2 observers from 2 different centers in 35 babies with 
typical genitalia (12 female, 23 male; 12 preterm, 23 term). 
Subsequently, the reliability of these parameters was assessed 
by 2 observers in 4 different centers in 66 babies with atypical 
genitalia: males with “mild nonspecific undermasculinization” 
(ie, isolated hypospadias [n=29] or isolated cryptorchidism 
[n=8]), and babies with 46,XY DSD (n=22), sex chromosome 
DSD (n=2), and 46,XX DSD (n=5) (23).
A collaborative multicenter study was then conducted in 8 
European clinical centers from July 2016 to July 2018, to es-
tablish reference data for the EGS in typical genitalia (Table 
2). For this purpose, the external genitalia of preterm infants, 
term infants up to 1 month and babies from 1 to 24 months 
of age were assessed by 1 observer per center and PS, EMS, 
EGS, GTL, and AGDl/u were determined. The following poten-
tial covariates were noted: maternal age, ethnicity, virilization 
and medication use in pregnancy, exposure to toxic products, 
smoking in pregnancy, history of consanguinity, gestational age 
at birth, weight and length at birth, weight and length at assess-
ment. Children with a major congenital malformation (central, 
cardiac, pneumologic, urologic) were excluded. In total, 181 
(105 male and 76 female) preterm (< 37 weeks) neonates, 378 
(178 male and 200 female term neonates), and 308 (153 male 
and 155 female) babies aged 1–24  months were assessed (a 
total of 686 babies). In 4 clinical centers the PS, EMS, EGS, and 
AGD l/u were obtained in babies with atypical genitalia (23).
Statistical analyses
The inter-observer reliability of the PS, EMS, and EGS and 
the intra- and inter-observer reliability for AGDs were assessed 
by Intraclass Correlation Coefficient (ICC) estimates and their 
95% confidence intervals (CI), based on absolute-agreement, 
2-way random-effect model (24). The median (10th– 90th cen-
tile) for EGS and EMS were generated. Spearman’s rho deter-
mined the correlation between EGS and EMS since both have 
a skewed distribution. The Bland–Altman analysis was used 
to assess agreement between the EGS and EMS. This method 
calculates the mean difference between 2 methods, and 95% 
limits (2 SD) of agreement of the differences between the 2 
methods (25). The mean (SD, 10th– 90th centile) for the dif-
ferent AGDs and AGD-ratios was calculated in typical and in 
atypical genitalia. Correlations of the different AGDs and the 
AGDl/u with weight, length and age were assessed by Pearson 
analysis. Potential covariates of the different AGDs and AGDl/u 
were assessed by linear regression. A  Spearman’s correlation 
Table 2. EGS in Female and Male Babies With Typical Genital Phenotypes in Different Gestational Age, Birth 
Weight, and Age Groups
EGS Values in Female and Male Babies With a Typical Genital Phenotype
FEMALE
All gestational ages, birth weights, age 0-24 months
N Median P10 P90
424 0 0 0
MALE
Gestational age (weeks) N Median P10 P90
<28 11 10 8.6 11.5
28-32,9 23 11.5 9.2 12
33-36,9 31 11.5 10.5 12
>37 178 12 10.5 12
Birth weight (g) N Median P10 P90
<1000 12 10 8.7 11.9
1000–1499 13 11.5 8.4 11.5
1500–2499 33 11.5 10.5 12
2500–4000 163 12 10.5 12
>4000 22 12 10.8 12
Age (months) N Median P10 P90
0–1 178 12 10.5 12
1–6 98 12 11.5 12
6–12 39 12 11 12
12–24 16 12 11.9 12
Abbreviations: EGS, External Genitalia Score
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was done to determine the relationship between EGS and 
AGDl/u. An independent-samples t-test was conducted to com-
pare AGDl/u in typical and atypical genitalia. All analyses were 
performed using the SPSS statistical package version 25.
Ethics
The study was approved by the local ethical committees of 
each participating center (Local IDs: Ghent: B670201628499, 
Medical University of Vienna 1872/2014), Rotterdam: MEC-
2016–706, Copenhagen: H-15014876 and RH-2015-210-
04146, Katowice: KNW/0022/KB1/158/I/16/17/18, Stockholm 
Karolinska University Hospital 2008/167-31/3, 2009-01-13, 
10-12-16. Messina: MEC 104/16. Informed consent was 
obtained from at least one parent or legal guardian for each child.
Results
Inter-observer reliability of EGS in comparison 
with EMS and PS, and of the various AGDs
As the EGS is a more refined modification of the EMS, 
we compared its reliability with the original EMS, and 
to the PS, which is historically the most widely used 
score. Inter-observer ICC (n=35) for EGS showed no 
case of disagreement between any scorer (excellent) in 
typical genitalia (ICC=1) and, the interobserver vari-
ability in atypical genitalia (n=66) was good (ICC=0.89; 
CI, 0.82–0.93). Likewise, inter-observer ICC for PS and 
EMS also showed no case of disagreement in typical 
and were moderate and good in atypical genitalia. Inter-
observer ICC for the different AGDs and genital tubercle 
length were moderate for AGDu and good for AGDl and 
genital tubercle length in typical male genitalia and good 
for AGDu, AGDl and genital tubercle length in atypical 
genitalia. Inter-observer ICC were good for AGDl and, 
AGDu in typical female genitalia. Intra-observer ICC for 
the different AGDs and genital tubercle length were good 
or excellent in both typical and atypical genitalia (23).
Reference data for genital tubercle length, EGS, 
AGDs and AGDl/u
As a new measuring instrument, we established refer-
ence data for EGS, including data in pre- and dysmature 
babies who present more often with atypical genitalia 
(12). In addition, we determined AGDs and AGDl/u to 
investigate correlations of EGS with other measures of 
genital virilization. In male term infants with typical 
genitalia, the mean (SD) genital tubercle length (n=174), 
AGDl, and AGDu (n=178) were 31.2 (5.4), 24.6 (4.7), 
and 47.6 (5.8) mm respectively. In female term infants 
with typical genitalia (n=200), the mean (SD) length of 
AGDl and AGDu were 14.8 (3.5) and 37.8 (4.5) mm, 
respectively. AGDl/u was independent of body weight 
Table 3. Genital Tubercle Length, AGDl/u in Male (light grey) and Female (dark grey) Babies With a Typical 
Genital Phenotype
Genital Tubercle Length in Male Infants With Typical Genital Phenotype
Gestational age (weeks) N Mean (mm) SD P10 P90
<28 11 21.5 4.7 12.0 27.4
28–33 21 27.5 4.7 20.3 27.4
33–37 27 28.3 4.7 21.8 34.0
>37 174 31.2 5.4 23.5 38.0
Age Group (months) full term infants
0–1 174 31.2 5.4 23.5 38.0
1–6 96 31.1 5.2 26.0 38.6
6–12 39 33.4 5.0 26.7 39.6
12–24 13 37.8 3.7 32.4 44.5
AGDl/u in male infants with typical genital phenotype
Gestational age (weeks)
<28 11 0.45 0.1 0.35 0.58
28–33 23 0.44 0.1 0.36 0.52
33–37 31 0.50 0.1 0.38 0.63
>37 178 0.52 0.1 0.41 0.65
Age Group (months) full term infants
0–1 178 0.52 0.1 0.42 0.65
1–6 97 0.48 0.1 0.38 0.56
6–12 39 0.49 0.1 0.41 0.60
12–24 15 0.49 0.1 0.34 0.63
AGDl/u in full-term male and female infants with typical genital phenotype
AGD ratio’s
AGDl/u 178 0.49 0.1 0.42 0.65
AGDl/u 200 0.39 0.1 0.29 0.48
Abbreviations: AGD, anogenital distance; AGDl/u, lower/upper AGD ratio; AGDu (AGDupper), measured from the center of the anus to the anterior 
base of the genital tubercle; AGDl (AGDlower), measured from the center of the anus to the base of the labioscrotal border.
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(Fig. 2). Although mean (SD) AGDl/u in male infants 
[0.49 (0.1)], significantly differs from AGDl/u in fe-
male infants [0.39 (0.1)], large overlap exists between 
both groups (Table 3, Fig. 2). AGD l/u in male neonates 
positively correlates with gestational age (r (243) = 0.3; 
P < 0.05). No univariate or bivariate correlation was de-
tected between AGD l/u and any of the other covariates 
(maternal age, ethnicity, center, virilization and/or medi-
cations used in pregnancy, exposure to toxic products 
or smoking during pregnancy). In typical male in-
fants, the median and 10th centile EGS gradually rise 
with increasing gestational age and birth weight due 
to increasing genital tubercle length and descent of the 
testes (Fig. 3A and 3B). In addition, the EGS 10th centile 
gradually increases with age up to 24 months. Median 
EGS in typical female premature and full-term babies up 
to 24 months is 0 (0-0) (Table 2).
Genital tubercle length, EGS, AGDs, and AGDl/u in 
children with atypical external genitalia
In babies with atypical genitalia, the EGS covers the 
whole phenotypic spectrum, resulting in scores ranging 
from 0 to 12 with large overlap between the various DSD 
categories (46,XX DSD, 46,XY DSD, and 45,X/46,XY 
DSD) (Table 4 and Fig. 3C). In male babies with atyp-
ical genitalia (46,XY DSD and “mild nonspecific 
undermasculinization”), AGDl/u (M=0.43, SD=0.11) 
is significantly shorter than AGDl/u in typical males 
(M=0.49, SD=0.09); t (95.1) = 4.8; P < 0.05), however 
AGDl/u widely varies in babies with atypical genitalia, 
with a mean 0.43 (0.1 SD) not different from mean 
AGDl/u 0.45 (0.1) in babies with typical genitalia (Fig. 2).
Correlation and agreement between scores and 
measures
AGDl, AGDu, and AGDl/u positively correlate with 
EGS in typical male full-term neonates as well as in 
babies with atypical genital phenotypes (rs (243) = 0.19; 
P < 0.05 and rs (78) = 0.35; P <0.05 respectively) (23). As 
expected, there is a strong, positive correlation between 
EGS and EMS in typical (rs (853) = 0.97; P < 0.05) and 
atypical genitalia (rs (110)  =  0.9; P  <  0.05) (23). The 
Bland-Altman analysis shows that optimal agreement 
weight (g)
12500100007500500025000
 A
G
D
l/u
,80
,60
,40
,20
atypical genital phenotype
male
female
Figure 2. Correlation between AGDl/u and weight in babies with 
typical genitalia and atypical genitalia. Abbreviations: ratio AGDl/u, 
lower/upper AGD ratio; AGDl, measured from the center of the anus 
to the base of the labioscrotal border; AGDu, measured from the 
center of the anus to the anterior base of the genital tubercle.
Figure 3. Boxplot with median and interquartile range of EGS (dark 
grey) in comparison with EMS (light grey). A) Results for typical 
male babies according to gestational age; B) Results for typical male 
babies according to birth weight; C) Results for babies with atypical 
genitalia and various DSD groups. Abbreviations: mild nonspecific 
undermasculinization, refers to isolated hypospadias or isolated 
cryptorchidism.
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between the 2 methods is reached for EMS/EGS results 
< 3 and > 9.5 (23).
Discussion
The EMS, developed by Ahmed et al in 2000 (22) pro-
vides an objective and standardized tool to describe ex-
ternal genitalia in male babies and has been correlated 
with various DSD-related outcomes (10–14). A major 
limitation of the EMS in the workup of an infant with 
atypical genitalia is that it cannot be applied in assigned 
females because of the gender-specific design and vo-
cabulary (eg, micropenis yes/no, scrotal fusion yes/no). 
Also, EMS does not capture the full phenotypic spec-
trum of genital variation that characterizes DSD condi-
tions due to its dichotomous nature. To overcome these 
problems, COST Action BM1303 Working Group  1 
modified the EMS in a gender-neutral and more re-
fined categorical scale, that better reflects the natur-
ally occurring variation (eg, by introducing the option 
posterior labioscrotal fusion). The resulting tool was 
termed the EGS and was subsequently validated in a 
large European multicenter study. EGS can be applied 
in both typical male and female babies and in babies 
who have variations in their genital characteristics. 
We provide normative data for premature, low-birth-
weight and full-term babies until the age of 2  years 
for a mixed European population. Such data are of 
particular relevance given the frequent association in 
males of intrauterine growth retardation with genital 
undermasculinization and the difficulties in assessing 
genital variation in preterm infants whose testes have 
not yet descended and whose penis has not yet reached 
its full-term length. Although the EGS can be used for 
the initial evaluation of babies with atypical genitalia, it 
cannot fully replace a more detailed qualitative genital 
description. The EGS does not inform on the presence 
of other atypical genital features such as complete or 
partial penoscrotal transposition, scrotal anomalies or 
degree of penile curvature. Moreover, EGS, like EMS, 
does not provide information on important internal 
genital characteristics in the context of DSD, such as 
the presence of a urogenital sinus or the location of the 
vaginal confluence in 46,XX babies who have CAH. 
Bland-Altman analysis reveals that EGS and EMS have 
least agreement in the group of children with atyp-
ical genitalia, that is, children who have an EGS be-
tween 3 and 9.5. In our data from 66 children with 
a DSD, the interquartile ranges are smaller for EGS 
compared with EMS, supporting our hypothesis that 
the EGS enables a more refined description of genital 
virilization. In addition, EGS is easy to use, helps to 
assess important landmarks of the external genitalia, 
can be implemented by physicians who do not regularly 
examine infants with variant genital development, and 
it serves as an alternative to genital photography, which 
has ethical constraints. Due to its objectivity and simple 
design, it is also very instrumental for the exchange of 
data on genital phenotypes between centers and re-
searchers, for example through large-scale registries 
such as I-DSD. Future research and clinical use of EGS 
will reveal whether specific EGS outcomes can be allo-
cated to specific diagnoses/mutated genes, but based on 
our preliminary data, it is expected that EGS will have 
little predictive value regarding the underlying diag-
nosis in most cases, given the large overlap between 
the various DSD categories. Reference data for the EGS 
in full-term, preterm, and low-birth-weight children, 
are of high relevance for a broad audience of pediat-
ricians and general practitioners. According to Ahmed 
et al (9), clinical evaluation by a specialized DSD-team 
is advised in proximal forms of hypospadias, isolated 
micropenis, isolated clitoromegaly, any form of familial 
hypospadias, and in those who have a combination of 
genital variations resulting in an EMS of less than 11. 
All these variations will result in a maximal EGS of 
Table 4. EGS Median,10th–90th Centile Scores and AGDl/u in Babies With Atypical Genital Phenotypes
EGS Scores in Babies With Atypical Genital Phenotypes
Group N Median P10 P90
46,XY DSD 46 8.5  5.5 11.5
Sex Chromosomal DSD 9 6.5    
Mild, nonspecific undermasculinization* 45 10.5  7.5 11.5
46,XX DSD 10 6  2.7 9
AGDl/u in Babies With Atypical Genital Phenotypes
Group N Mean SD P10 P90
46,XY DSD 33 0.44 0.13 0.23 0.60
mild, nonspecific undermasculinization* 43 0.42 0.10 0.28 0.54
46,XX DSD 7 0.45 0.10 0.32 /
Abbreviations: AGDu, measured from the center of the anus to the anterior base of the genital tubercle; AGDl, measured from the center of the anus 
to the base of the labioscrotal border; AGDl/u, lower/upper AGD ratio; EGS, External Genitalia Score. *mild nonspecific undermasculinization refers 
to males with isolated cryptorchidism or isolated hypospadias
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10.5, corresponding to P10 in full-term male infants. 
Therefore, based on our data, we advise referral to a 
specialized DSD team for any full-term infant who has 
an EGS > 0 and ≤ 10.5 (or ≤ P10), and of any preterm 
or low-birth-weight infant who has an EGS > 0 and ≤ 
P10 for gestational age or birth weight, independent 
of maternal age, ethnicity, virilization and/or medica-
tions used in pregnancy, exposure to toxic products, or 
maternal smoking. Of note, the obtained EGS will not 
lead to a specific diagnosis in an infant who has variant 
genitalia, but it may justify further genetic, biochem-
ical, and hormonal diagnostic investigations. Further 
research is mandatory to determine whether this rec-
ommendation will require adjustments in the future.
The anogenital distance has been shown to be a 
surrogate marker of prenatal androgen exposure and 
has been correlated to various endocrine-reproductive 
outcomes (26–28). Although it adds to the description 
of the external genitalia (29), its clinical use is limited 
as it is relatively time-consuming and measurements 
are hard to standardize among different observers. 
As AGD is known to correlate with anthropometric 
variables, which was confirmed in our study, the AGD 
ratio may represent a more useful marker. In our study, 
AGDl/u followed a normal distribution and did not 
correlate with any of the anthropometric variables. 
Moreover, while mean AGDl/u significantly differs be-
tween typical males and typical females, this measure 
underscores the naturally encountered variation in 
genital phenotypes, both in typical males and females 
and in children who have a DSD, as becomes obvious 
from Fig. 2. As expected, AGDl/u correlates with EGS 
in undermasculinized infants, both measurements in-
dependently reflecting the degree of prenatal androgen 
exposure.
A major strength of our study is its multicenter de-
sign, allowing data collection in a large European 
sample in a relatively short period. At the same time, this 
multicenter approach may constitute a weakness, since 
some measurements, such as AGD and genital tubercle 
length are prone to larger inter-observer variability. This 
was also confirmed by the variable ICC scores obtained 
for these measures in our study and this may explain 
the relatively large SD obtained for these parameters. In 
addition the assessment of children with atypical geni-
talia was performed in 4 out of 8 centers, which could 
have led to recruitment bias.
In conclusion, the EGS is a reliable and easy-to-use 
tool that allows objective and detailed description of 
typical and variant external genitalia in neonates and 
infants. This facilitates clinical management and data 
exchange across centers, to study outcomes or draw 
genotype-phenotype correlations. We provide European 
reference data for term and premature neonates, for 
neonates who have low birth weight and for toddlers 
up to 24 months.
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